Skip to main content

Table 1 Characteristics between young TBM patients in stroke group and non-stroke group

From: Acute ischemic stroke in young adults with tuberculous meningitis

  Total (n = 52) Stroke group (n = 12) Non-stroke group (n = 40) p value
Age (years) 30.3 ± 9.9 35.9 ± 10.8 28.4 ± 9.3 0.040
Sex (male, %) 33 (63.5%) 8 (66.7%) 25 (62.5%) 1.000
Smoking, % 11 (21.2%) 2 (25.0%) 9 (22.5%) 1.000
HIV, % 3 (5.8%) 2 (16.7%) 1 (2.5%) 0.254
Clinical presentations
 Fever, % 44 (84.6%) 10 (83.3%) 34 (85.0%) 1.000
 Headache, % 39 (75.0%) 12 (100%) 27 (67.5%) 0.024
 Vomiting, % 17 (32.7%) 5 (41.7%) 12 (30.0%) 0.686
 Altered consciousness, % 17 (32.7%) 5 (41.7%) 12 (30.0%) 0.686
 Visual disturbance, % 6 (11.5%) 2 (16.7%) 4 (10.0%) 0.905
 Cranial nerve palsy, % 8 (15.4%) 4 (33.3%) 4 (10.0%) 0.131
 Focal weakness, % 12 (23.1%) 5 (41.7%) 7 (17.5%) 0.176
 Neck stiffness, % 21 (40.4%) 7 (58.3%) 14 (35.0%) 0.267
 Seizure, % 8 (15.4%) 2 (16.7%) 6 (15.5%) 1.000
GCS score
 3–10 7 (13.5%) 4 (33.3%) 3 (7.5%)  
 11–15 45 (86.5%) 8 (66.7%) 37 (92.5%) 0.069
Stage of TBM
 Stage I 36 (69.2%) 7 (58.3%) 29 (72.5%)  
 Stage II 9 (17.3%) 1 (8.3%) 8 (20.0%)  
 Stage III 7 (13.5%) 4 (33.4%) 3 (7.5%) 0.195
Clinical outcome
Good outcome (mRS = 0) 35 (67.3%) 5 (41.7%) 30 (75.0%)  
Intermediate outcome (mRS 1–2) 9 (17.3%) 3 (25.0%) 6 (12.5%)  
Poor outcome (mRS 3–5 and death) 8 (15.4%) 4 (33.3%) 4 (10.0%) 0.024
  1. TBM indicates tuberculous meningitis; HIV indicates human immunodeficiency virus; GCS indicates Glasgow Coma Scale; mRS indicates Modified Rankin Scale